Board of Directors

Chairman
Since retiring as Chairman of Syngenta Corporation in the U.S. in 2003, Bob Woods has been a business management consultant. He works with various companies, both public and private, in the agricultural, biotechnology and specialty chemical industries. Mr. Woods is also CEO of Athena Biotechnologies Inc and is on several boards of both private corporations and biotech start-up companies. Prior to his work at Syngenta, Mr. Woods held several key leadership roles within the agricultural products business including serving as President of the U.S. and Canadian business of Zeneca Ag Products Group prior to its merger with Novartis to form Syngenta. He is also past chairman of the Crop Life America industry association and currently serves on their Foundation Board.

Vice President, Investments, GrowthWorks (WVIS) Ltd.Mr. Regan joined GrowthWorks in early 2003, bringing over a decade of life sciences venture capital and pharmaceutical industry experience. He has been active in both company creation and the strategic growth of portfolio companies. Mr. Regan has an Honours BSc (with distinction) from the University of Guelph and an MBA (Dean’s List) from McMaster University. He also currently serves on the Boards of Cytochroma, Inc., Kytogenics Limited, Dynacon, Inc., Molecular Templates, Inc., SimEx Inc., Sunnybrook Working Ventures Medical Discovery Fund Inc. and Working Ventures CMDP Queen’s Scientific Breakthrough Fund Inc.

CEO, Director
Mr. Todaro co-founded Targeted Growth in 1999, based on novel cell cycle regulator technologies. Mr. Todaro has worked in agribusiness since 1992 directing investments in dairy processing and timber plantations. He is the former General Manager of Alamar Farms Ltd., a Canadian dairy processor located in Vancouver, B.C., and sits on the Board of Directors of BonLac Dairies in Panama City, Panama. Prior to rejoining TGI, Mr. Todaro served as Senior Vice President of Mergers & Acquisitions at PayPal. Mr. Todaro was responsible for all aspects of M&A, both national and International. He was also involved in raising over $200 Million in equity capital and the IPO of PayPal (PYPL) for $1.2 Billion in 2002. He holds a Bachelor’s degree from The Colorado College and a Master’s in Economics from Stanford University.

Professor Simon Best is a serial entrepreneur who built three biotechnology ventures as founding CEO between 1991 and 2005- Zeneca Plant Science, Roslin BioMed and Ardana. He is currently Entrepreneur-in-Residence at TVM Capital, Chairman of the Advisory Board of PAR Equity and a non-Executive Director of Polytherics Ltd. and Entelos Inc. Professor Best was previously Chairman of Ardana Plc. and Neuro3D SA, a Director of Avesthagen Pvt. Ltd. in Bangalore, India and a Director of Direvo Biotech AG.

Professor Best was the Chairman of the UK BioIndustry Association (BIA) from 2006-2007, the Vice-Chairman of BIO in the US from 1994-96 and a member of the Board and Chair of the Bioethics Committee from 1998-2005.

Professor Best received his Bachelor of Music from the University of York in 1977 and his MBA from London Business School (LBS) in 1985 where he was the recipient of the Alan Patricof and Associates (APAX) Venture Capital prize. In 2004, he was awarded an Honorary Ph.D from the University of York for his contributions to Music, Biotechnology and Medicine. In 2007, he was elected a Fellow of the Royal Society of Edinburgh (FRSE) and awarded the LBS Alumni Achievement Prize. In 2008, he was awarded an OBE and made an Honorary Professor of Medicine by the University of Edinburgh.

.